Timothy M. Murphy

Statistics

Publications

Citations

482

H-Index

Active since

2000

Affiliations

Tetraphase Pharmaceuticals (United States)(Current)

Pearl River Community College

Timothy M. Murphy is an author at Tetraphase Pharmaceuticals (United States) specializing in antibiotic resistance, antibacterial pharmacology, and antimicrobial resistance.

Publications per year

2000–2017

Publications

In Vitro and In Vivo Activities of Tigecycline (GAR-936), Daptomycin, and Comparative Antimicrobial Agents against Glycopeptide-Intermediate<i>Staphylococcus aureus</i>and Other Resistant Gram-Positive Pathogens

Peter J. Petersen, Patricia A. Bradford, Jason Weiss et al. · Antimicrobial Agents and Chemotherapy · 2002 · 168 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Tricyclic GyrB/ParE (TriBE) Inhibitors: A New Class of Broad-Spectrum Dual-Targeting Antibacterial Agents

Leslie W. Tari, Xiaoming Li, Michael Trzoss et al. · PLoS ONE · 2013 · 104 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

Therapeutic Efficacy of GAR-936, a Novel Glycylcycline, in a Rat Model of Experimental Endocarditis

Timothy M. Murphy, Jacqueline M. Deitz, Peter J. Petersen et al. · Antimicrobial Agents and Chemotherapy · 2000 · 79 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

In Vitro and In Vivo Activities of Novel 6-Methylidene Penems as β-Lactamase Inhibitors

Jason Weiss, Peter J. Petersen, Timothy M. Murphy et al. · Antimicrobial Agents and Chemotherapy · 2004 · 54 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Eravacycline (TP-434) Is Efficacious in Animal Models of Infection

Trudy H. Grossman, Timothy M. Murphy, Andrew Slee et al. · Antimicrobial Agents and Chemotherapy · 2015 · 44 citations · Full text

Medicine, Infectious Diseases, Pharmacology +16

1–5 of 6